American International Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-68,660
| Closed | -$685K | – | 2200 |
|
|
2024
Q1 | $685K | Buy |
68,660
+823
| +1% | +$8.21K | ﹤0.01% | 1501 |
|
|
2023
Q4 | $669K | Sell |
67,837
-275
| -0.4% | -$2.71K | ﹤0.01% | 1503 |
|
|
2023
Q3 | $521K | Buy |
68,112
+2,422
| +4% | +$18.5K | ﹤0.01% | 1580 |
|
|
2023
Q2 | $491K | Sell |
65,690
-266
| -0.4% | -$1.99K | ﹤0.01% | 1655 |
|
|
2023
Q1 | $440K | Buy |
65,956
+1,311
| +2% | +$8.74K | ﹤0.01% | 1668 |
|
|
2022
Q4 | $498K | Sell |
64,645
-235
| -0.4% | -$1.81K | ﹤0.01% | 1591 |
|
|
2022
Q3 | $690K | Buy |
64,880
+1,589
| +3% | +$16.9K | 0.01% | 1383 |
|
|
2022
Q2 | $515K | Buy |
63,291
+6,066
| +11% | +$49.4K | ﹤0.01% | 1587 |
|
|
2022
Q1 | $410K | Sell |
57,225
-4,026
| -7% | -$28.8K | ﹤0.01% | 1836 |
|
|
2021
Q4 | $1.05M | Buy |
61,251
+45,851
| +298% | +$785K | 0.01% | 1405 |
|
|
2021
Q3 | $354K | Buy |
15,400
+3,561
| +30% | +$81.9K | ﹤0.01% | 2075 |
|
|
2021
Q2 | $432 | Buy |
+11,839
| New | +$432 | ﹤0.01% | 2014 |
|